Literature DB >> 23428627

Evaluation of radiosurgery techniques--cone-based linac radiosurgery vs tomotherapy-based radiosurgery.

Ho Yin Yip1, Wing Lun A Mui, Joseph W Y Lee, Winky Wing Ki Fung, Jocelyn M T Chan, G Chiu, Maria Y Y Law.   

Abstract

Performances of radiosurgery of intracranial lesions between cone-based Linac system and Tomotherapy-based system were compared in terms of dosimetry and time. Twelve patients with single intracranial lesion treated with cone-based Linac radiosurgery system from 2005 to 2009 were replanned for Tomotherapy-based radiosurgery treatment. The conformity index, homogeneity index (HI), and gradient score index (GSI) of each case was calculated. The Wilcoxon matched-pair test was used to compare the 3 indices between both systems. The cases with regular target (n = 6) and those with irregular target (n = 6) were further analyzed separately. The estimated treatment time between both systems was also compared. Significant differences were found in HI (p = 0.05) and in GSI (p = 0.03) for the whole group. Cone-based radiosurgery was better in GSI whereas Tomotherapy-based radiosurgery was better in HI. Cone-based radiosurgery was better in conformity index (p = 0.03) and GSI (p = 0.03) for regular targets, whereas Tomotherapy-based radiosurgery system performed significantly better in HI (p = 0.03) for irregular targets. The estimated total treatment time for Tomotherapy-based radiosurgery ranged from 24 minutes to 35 minutes, including 15 minutes of pretreatment megavoltage computed tomography (MVCT) and image registration, whereas that for cone-based radiosurgery ranged from 15 minutes for 1 isocenter to 75 minutes for 5 isocenters. As a rule of thumb, Tomotherapy-based radiosurgery system should be the first-line treatment for irregular lesions because of better dose homogeneity and shorter treatment time. Cone-based Linac radiosurgery system should be the treatment of choice for regular targets because of the better dose conformity, rapid dose fall-off, and reasonable treatment time.
Copyright © 2013 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23428627     DOI: 10.1016/j.meddos.2013.01.001

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Dosimetric comparison of different treatment modalities for stereotactic radiotherapy.

Authors:  Shih-Ming Hsu; Yuan-Chun Lai; Chien-Chung Jeng; Chia-Ying Tseng
Journal:  Radiat Oncol       Date:  2017-09-16       Impact factor: 3.481

2.  Prediction of conical collimator collision for stereotactic radiosurgery.

Authors:  Jeonghoon Park; Ryan McDermott; Sangroh Kim; M Saiful Huq
Journal:  J Appl Clin Med Phys       Date:  2020-07-06       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.